According to the new research report published by Precedence Research, titled “Sphygmomanometer Market (By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer; By Operation: Electric, Manual, Automatic, Semi-automatic; By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted; By End User: Hospitals, Ambulatory Surgical Centers & Clinics, Home Healthcare, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the global sphygmomanometer market size is expected to be worth around US$ 4.8 billion by 2030 and is poised to record a yearly growth rate of 9.06% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on sphygmomanometer market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall sphygmomanometer market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2233
The study also provieds important advancements in organic and inorganic growth strategies in the worldwide sphygmomanometer market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of sphygmomanometer market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Report Scope of the Sphygmomanometer Market
| Report Coverage | Details |
| Market Size in 2022 | USD 2.4 Billion |
| Market Size by 2030 | USD 4.8 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.06% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Operation, Configuration, End User, and Geography |
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the sphygmomanometer market.
Some of the prominent players in the sphygmomanometer market include are A & D Company (India), Welch Allyn (U.S.), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Omron (Japan), Beurer GmbH (Germany), Paul Hartmann AG (Germany), Microlife Corporation (Switzerland), American Diagnostic (U.S.), Rossmax International (Japan), Rudolf Riester GmbH (Germany), Briggs Healthcare (U.S.), Terumo Corporation (Japan)
Market Segmentations
By Product
- Electronic Sphygmomanometer
- Aneroid Sphygmomanometer
- Mercury Sphygmomanometer
By Operation
- Electric
- Manual
- Automatic
- Semi-automatic
By Configuration
- Portable
- Desk Mounted
- Floor Standing
- Wall Mounted
By End-User
- Hospitals
- Ambulatory Surgical Centers & Clinics
- Home Healthcare
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, segment, and project the global market size for sphygmomanometer market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyze their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyze the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sphygmomanometer Market
5.1. COVID-19 Landscape: Sphygmomanometer Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sphygmomanometer Market, By Product
8.1. Sphygmomanometer Market, by Product, 2022-2030
8.1.1. Electronic Sphygmomanometer
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Aneroid Sphygmomanometer
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Mercury Sphygmomanometer
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Sphygmomanometer Market, By Operation
9.1. Sphygmomanometer Market, by Operation, 2022-2030
9.1.1. Electric
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Manual
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Automatic
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Semi-automatic
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Sphygmomanometer Market, By Configuration
10.1. Sphygmomanometer Market, by Configuration, 2022-2030
10.1.1. Portable
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Desk Mounted
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Floor Standing
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Wall Mounted
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Sphygmomanometer Market, By End-User
11.1. Sphygmomanometer Market, by End-User, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Ambulatory Surgical Centers & Clinics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Home Healthcare
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Sphygmomanometer Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.4. Market Revenue and Forecast, by End-User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 13. Company Profiles
13.1. A & D Company (India)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Welch Allyn (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Koninklijke Philips N.V. (Netherlands)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. General Electric (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Omron (Japan)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Beurer GmbH (Germany)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Paul Hartmann AG (Germany)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Microlife Corporation (Switzerland)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. American Diagnostic (U.S.)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Rossmax International (Japan)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global sphygmomanometer market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for sphygmomanometer are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
